Physician profile
Omar A Bakr
NPI 1164499307
$6,633.69
in general payments reported to CMS, 2019-2025
25 companies · $2,019 in 2025
The $2,019 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,453 · 2020: $321 · 2021: $486 · 2022: $753 · 2023: $1,422 · 2024: $180 · 2025: $2,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,910 · Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,909.97 |
| Food and Beverage | $710.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,476.63 | 2021-2025 | Micra |
| Medtronic Vascular, INC. | $1,188.65 | 2019 | |
| Medical Device Business Services, INC. | $1,045.89 | 2023 | Carto 3 |
| Abbott Laboratories | $881.54 | 2023-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Perclose Prostyle |
| Novartis Pharmaceuticals Corporation | $665.56 | 2019-2023 | |
| Amgen INC. | $274.42 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $263.96 | 2019-2024 | Xarelto |
| Philips North America LLC | $126.87 | 2022-2024 | (5044) Mcot |
| E.R. Squibb & Sons, L.L.C. | $118.36 | 2022 | |
| Inari Medical, INC. | $76.52 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $69.36 | 2020-2024 | |
| Atricure, INC. | $61.74 | 2023 | |
| Chiesi USA, INC. | $46.10 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.46 | 2019-2022 | |
| Boston Scientific Corporation | $39.70 | 2022-2024 | Bodyguardian |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $35.83 | 2023 | Carto 3 |
| Shockwave Medical, INC | $34.76 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bardy Diagnostics, INC. | $33.48 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.97 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $26.46 | 2023 | Brilinta, Farxiga |
| Lantheus Medical Imaging, INC. | $22.98 | 2024 | |
| Cardinal Health 200 LLC | $18.96 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.00 | 2023 | |
| Teleflex LLC | $16.41 | 2019 | |
| Cordis US Corp. | $16.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Bakr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.